Anzeige
Mehr »
Samstag, 28.06.2025 - Börsentäglich über 12.000 News
Blockbuster-Bohrergebnisse: Gold-Antimon-Fund in Nevada trifft geopolitischen Nerv
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0DLB7 | ISIN: CA88337V1004 | Ticker-Symbol: TTX
Frankfurt
27.06.25 | 08:00
0,104 Euro
+5,05 % +0,005
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
THERALASE TECHNOLOGIES INC Chart 1 Jahr
5-Tage-Chart
THERALASE TECHNOLOGIES INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,1030,12727.06.

Aktuelle News zur THERALASE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
00:06Theralase Technologies Inc: Theralase to extend warrant expiry by three years1
THERALASE Aktie jetzt für 0€ handeln
FrTheralase Technologies Inc.: Theralase(R) Extends Warrants260Toronto, Ontario--(Newsfile Corp. - June 27, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light...
► Artikel lesen
18.06.Theralase Technologies Inc: Theralase 2,885,000-share private placement1
17.06.Theralase Technologies Inc: Theralase closes $571,000 private placement4
17.06.Theralase Technologies Inc.: Theralase(R) Closes Non-Brokered Private Placement171Toronto, Ontario--(Newsfile Corp. - June 17, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light...
► Artikel lesen
12.06.Theralase Technologies Inc: Theralase completes AGSM1
12.06.Theralase Technologies Inc.: Theralase Completes Annual General and Special Meeting193Toronto, Ontario--(Newsfile Corp. - June 12, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light...
► Artikel lesen
09.06.Earnings Call Transkript: Theralase Technologies verfehlt EPS im Q1 2025, Aktie fällt3
05.06.Theralase Technologies Inc: Theralase to hold AGSM June 114
05.06.Theralase Technologies Inc.: Theralase Annual General Meeting359Toronto, Ontario--(Newsfile Corp. - June 5, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light...
► Artikel lesen
30.05.Theralase Technologies Inc.: Theralase(R) 1Q2025 Financial Statements364Toronto, Ontario--(Newsfile Corp. - May 30, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light...
► Artikel lesen
29.05.Theralase Technologies Inc.: Theralase to Present Groundbreaking Research at ASTRO 2025431Toronto, Ontario--(Newsfile Corp. - May 29, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light...
► Artikel lesen
20.05.Theralase Technologies Inc.: Theralase Provides Corporate Update198Toronto, Ontario--(Newsfile Corp. - May 20, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the...
► Artikel lesen
05.05.Theralase Technologies Inc.: Theralase Clinical Data Presented at Canadian Bladder Cancer Forum and American Urological Association284Toronto, Ontario--(Newsfile Corp. - May 5, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the...
► Artikel lesen
28.04.Theralase Technologies Inc: Theralase finds drug inhibits deubiquitinating enzymes2
28.04.Theralase uncovers new use-case for flagship drug3
28.04.Theralase Technologies Inc.: Theralase Discovers New Mechanism of Action of Lead Drug286Toronto, Ontario--(Newsfile Corp. - April 28, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the...
► Artikel lesen
23.04.Theralase Technologies Inc: Theralase 1,995,829-share private placement2
15.04.Theralase Technologies Inc: Theralase closes $419,124 private placement2
14.04.Theralase Technologies Inc.: Theralase(R) Closes Non-Brokered Private Placement356Toronto, Ontario--(Newsfile Corp. - April 14, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the...
► Artikel lesen
Weiter >>
55 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1